Brief: Nanexa Signs Additional Evaluation Agreement
Oct 13 (Reuters) - Nanexa AB NANEXA.ST :
* NANEXA SIGNS ADDITIONAL EVALUATION AGREEMENT
* HAS SIGNED AN ADDITIONAL SO-CALLED MATERIAL TRANSFER AND
FEASIBILITY STUDY AGREEMENT WITH ONE OF COMPANY'S EXISTING
CUSTOMERS, FOR EVALUATION OF PHARMASHELL® TECHNOLOGY WITH A
SPECIFIC BIOLOGICAL DRUG SUBSTANCE
Source text for Eikon: ID:nMFN8hsHQR
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nanexa AB
See all newsNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Brief: Nanexa And Novo Enter Global License, Collaboration Deal
Brief: Forge Nano And Nanexa To Develop Gmp-Compatible Ald Manufacturing Equipment
Brief: Nanexa Q2 Revenue Amounted To SEK 1.7 Million
Sweden's Nanexa Q1 revenue falls, loss widens